Omixon is a global molecular diagnostics company, empowering clinical labs with technologies to improve patient outcomes by commercializing disruptive innovations specializing in targeted applications for Next Generation Sequencing (NGS). The Omixon Holotype HLA™ product combines a targeted HLA Assay and the Omixon HLA Twin™ software to deliver the most accurate high-resolution HLA genotyping available. Omixon maintains an active grant-funded research program and assists scientists and clinicians to analyze the most challenging genomic regions including HLA, KIR and ABO.
To read the first part of the article, click here… Much much much later… After all the sequencing and genotyping is finally done, it’s time to measure how good the results are. As usual, there is no single, perfect measure for …more
Welcome to the latest video in Omixon’s “Learn Me” Video Series. In this short video, we’re going to show you the Genome Browser of HLA TWIN and its advanced functions. You may want to watch the video for the basic functions …more